Sulfonylurea

The results of adding vildagliptin to metformin…. 

Richard S. Beaser, MD This week’s excerpt covers the following topics: Knowing the options for treatment Determining medication selection Clinical markers for the dominant underlying pathophysiology The three stages to glucose patterns

Dietary interventions’s impact on HbA1c and hypoglycemia also assessed…. 

Researchers looked at whether exposure to metformin is associated with a decreased risk of bladder cancer…. 

Elderly type 2 diabetic patients particularly vulnerable…. 

Does medication type make a difference?… 

Approximately two-fold increase…. 

Post market study results…. 

Tolerability in type 2 diabetes patients aged 65 years and older…. 

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …